Sudarshan Pharma Industries Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 20,000 shares,. Its Average Traded Price (ATP) is ₹36.79, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 4000 @ ₹37.24.
Sudarshan Pharma Industries has an upper circuit limit of ₹39.10 and a lower circuit limit of ₹35.38. The total value traded stands at ₹7.36 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 4000. Sudarshan Pharma Industries also offers a dividend yield of 0%.
Sudarshan Pharma Industries Share Price Chart
Sudarshan Pharma Industries Share Key Metrics
Volume
20000.00
Market Cap
947.65 CR
LTQ@LTP
4000@37.24
ATP
36.79
Var Margin
53.5 %
Circuit Range
35.38-39.1
Delivery %
0 %
Value
7.36 L
ASM/GSM
No
Market Lot
4000
Sudarshan Pharma Industries Resistance and Support
Pivot 37.42
Resistance
First Resistance
37.84
Second Resistance
38.38
Third Resistance
38.8
Support
First Support
36.88
Second Support
36.46
Third Support
35.92
Sudarshan Pharma Industries Shareholding Pattern
View More- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Sudarshan Pharma Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-06-18 | Issue Of Warrants |
| 2026-05-21 | Others |
| 2026-05-15 | Others |
| 2026-04-30 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-10-18 | Half Yearly Results |
| 2025-08-14 | Quarterly Results |
| 2025-06-19 | Others |
| 2025-04-24 | Audited Results |
| 2025-01-10 | To consider issue of Warrants |
| 2024-10-31 | Half Yearly Results |
| 2024-09-30 | Stock Split |
| 2024-07-04 | Others |
| Split Ratio | Split Date | |
|---|---|---|
| 10:1 | 2024-11-22 | View More |
Sudarshan Pharma Industries News
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Sudarshan Pharma Industries updated on its proposed acquisition of 9.50% equity in Med Therapy Biotechnology Inc., USA. The proposal, along with 1.50% acquisitions by promoters, is under due diligence and awaiting board approvals from Med Therapy.
Sep 15 2026 14:13:35
Sudarshan Pharma Industries Ltd - 543828 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Sudarshan Pharma Industries' promoter group pledged 2.92% of the company's shares (70.62 lakh shares) to Gangabase Private Limited. This pledge acts as security for a loan taken by Sudarshan Pharma Industries Limited.
Sep 09 2026 19:59:33
Sudarshan Pharma Industries Ltd - 543828 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Sudarshan Pharma Promoter Hemal Mehta released 20 lakh pledged equity shares, which is 0.83% of the company's total share capital. The shares were originally pledged to secure a personal loan for the promoter.
Sep 09 2026 19:57:43
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Acquisition
Sudarshan Pharma Industries acquired a 9.50% stake in MedTherapy Biotechnology Inc., a US-based cancer cell and gene therapy company. This acquisition will enable entry into the US market, access new customer bases, and expand product and service offerings.
Sep 05 2026 19:34:25
Sudarshan Pharma Industries Management
| Name | Position |
|---|---|
| Nirav Shah | Company Secretary & Compliance Officer |
| Hemal Vasantrai Mehta | Chairman & Managing Director |
Sudarshan Pharma Industries Similar Stocks
Sudarshan Pharma Industries FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SUDARSHAN
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC